A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer

NCT04236362 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Gynecological Cancer

Interventions

DRUG: TQB2450
DRUG: Anlotinib

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.